Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Neuropharmacology

• Publication date

  1998-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0028-3908(98)00077-XPMID 9776388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs

  2005cited by this paper
• Pharmacological validation of a novel animal model of anticipatory anxiety in mice

  2005cited by this paper
• Attenuation of defensive threat and attack in wild rats (Rattus rattus) by benzodiazepines

  2004cited by this paper
• Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential “animal model” for the study of panic disorder?

  2004cited by this paper
• Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat

  2004cited by this paper
• Panic disorder : clinical, biological, and treatment aspects

  1999cited by this paper
• Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents Comparison with diazepam and buspirone

  1998cited by this paper
• Behavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs

  1997cited by this paper
• The effects of selective monoamine oxidases A or B inhibitors on the anxiogenic-like behaviour in mice

  1997cited by this paper
• Genetic differences in the mouse defense test battery

  1997cited by this paper
• A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.

  1997influential reference
• Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile.

  1996cited by this paper
• THE DRAMBALLET STUDIO

  1996cited by this paper
• The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA

  1996cited by this paper
• Evidence that the behaviors in the Mouse Defense Test Battery relate to different emotional states: a factor analytic study.

  1996influential reference
• Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.

  1996cited by this paper
• MAOIs in the Contemporary Treatment of Depression

  1995cited by this paper
• Serotonergic compounds in panic disorder, obsessive‐compulsive disorder and anxious depression: A concise review

  1995cited by this paper
• Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity.

  1995cited by this paper
• Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine

  1995cited by this paper
• Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders

  1995cited by this paper
• Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam.

  1995influential reference
• Reversible Inhibitors of Monoamine Oxidase A in Anxiety Disorders

  1995cited by this paper
• A model of ‘antipredator’ defense in Swiss‐Webster mice: effects of benzodiazepine receptor ligands with different intrinsic activities

  1995influential reference
• 5-HT1A agonists modulate mouse antipredator defensive behavior differently from the 5-HT2A antagonist pirenperone.

  1995influential reference
• Newer and Older Monoamine Oxidase Inhibitors

  1995cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, 4th Ed.

  1994cited by this paper
• Serotonin in Anxiety and Related Disorders

  1993cited by this paper
• The comparative pharmacology of new antidepressants.

  1993influential reference
• Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety.

  1993cited by this paper
• Psychopharmacology of panic

  1993cited by this paper
• Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.

  1992cited by this paper
• Neurotransmitters in the Dorsal Periaqueductal Grey and Animal Models of Panic Anxiety

  1991cited by this paper
• An animal model of panic disorder

  1991cited by this paper
• Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.

  1991cited by this paper
• 5-HT and mechanisms of defence

  1991cited by this paper
• New concepts in anxiety

  1990cited by this paper
• Antipanic drug treatments: failure to exhibit anxiolytic-like effects on defensive burying behavior.

  1990cited by this paper
• Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders

  1990cited by this paper
• Validation of aversion towards open space and height as a measure of anxiety in the genetically based animal model of depression.

  1990cited by this paper
• Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

  1989cited by this paper
• Profiles of the antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety.

  1988cited by this paper
• 'Taming' of wild rats (Rattus rattus) by 5HT1A agonists buspirone and gepirone.

  1988cited by this paper
• Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase

  1988cited by this paper
• A serotonin hypothesis of panic disorder

  1988cited by this paper
• Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology

  1987cited by this paper
• 2 – Monoamine oxidase inhibitor antidepressants

  1985cited by this paper
• Rat brain concentrations of 5-hydroxytryptamine following acute and chronic administration of MAO-inhibiting antidepressants.

  1984cited by this paper
• Regional concentrations of cerebral amines: effects of tranylcypromine and phenelzine

  1983cited by this paper
• Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain

  1983cited by this paper
• The contribution of 5-hydroxyindolepyruvic acid to cerebral 5-hydroxyindole metabolism.

  1971cited by this paper
• Effects of Iproniazid in Depressive Syndromes

  1959cited by this paper
• diagnostic and statistical manual of mental disorders,

  year unknowncited by this paper

• From warrior genes to translational solutions: novel insights into monoamine oxidases (MAOs) and aggression

  2021cites this paper
• Restoration of Noradrenergic Function in Parkinson’s Disease Model Mice

  2021cites this paper
• Serotonin and aggression

  2019cites this paper
• Antinociceptive Effects of the Antidepressant Phenelzine are Mediated by Context-Dependent Inhibition of Neuronal Responses in the Dorsal Horn.

  2018cites this paper
• Kinetics, mechanism, and inhibition of monoamine oxidase

  2018cites this paper
• Risk assessment and serotonin: Animal models and human psychopathologies.

  2017cites this paper
• Panic-modulating effects of alprazolam, moclobemide and sumatriptan in the rat elevated T-maze.

  2016cites this paper
• The role of monoamine oxidase A in aggression: Current translational developments and future challenges.

  2016cites this paper
• Tests for Anxiolytic Activity

  2015cites this paper
• The role of the serotonergic system at the interface of aggression and suicide.

  2013cites this paper
• Effects of antidepressant treatment on mice lacking brain‐derived neurotrophic factor expression through promoter IV

  2013cites this paper
• Antidepressant-like effect of the novel MAO inhibitor 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole (2-DMPI) in mice.

  2012cites this paper
• Severe Serotonin Depletion after Conditional Deletion of the Vesicular Monoamine Transporter 2 Gene in Serotonin Neurons: Neural and Behavioral Consequences

  2011cites this paper
• Maladaptive defensive behaviours in monoamine oxidase A-deficient mice.

  2011cites this paper
• Amino acid and biogenic amine concentrations during experimental autoimmune encephalomyelitis and the disease-modifying effects of phenelzine treatment

  2011cites this paper
• Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.

  2011cites this paper
• The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).

  2011cites this paper
• Learning new tricks from an old dog: using experimental autoimmune encephalomyelitis to study comorbid symptoms in multiple sclerosis.

  2011cites this paper
• Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models.

  2011cites this paper
• Gene expression profile analysis of genes in rat hippocampus from antidepressant treated rats using DNA microarray

  2010cites this paper
• Phenelzine: An Old Drug That May Hold Clues to The Development of New Neuroprotective Agents

  2010cites this paper
• Glucocorticoid status affects antidepressant regulation of locus coeruleus tyrosine hydroxylase and dorsal raphé tryptophan hydroxylase gene expression.

  2009cites this paper
• Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response.

  2008cites this paper
• Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.

  2008cites this paper
• Chapter 2.5 Unconditioned models of fear and anxiety

  2008cites this paper
• Flavonoids from Tilia americana with anxiolytic activity in plus-maze test.

  2008cites this paper
• Phenelzine Causes an Increase in Brain Ornithine that is Prevented by Prior Monoamine Oxidase Inhibition

  2008cites this paper
• Involvement of alpha1-adrenergic receptors in tranylcypromine enhancement of nicotine self-administration in rat

  2007cites this paper
• Cocaine exposure during adolescence affects anxiety in adult mice.

  2007cites this paper
• Anxiety and panic responses to a predator in male and female Ts65Dn mice, a model for Down syndrome

  2006cites this paper
• Animal Models of Anxiety

  2006cites this paper
• Monoamine Oxidase Inhibition Dramatically Increases the Motivation to Self-Administer Nicotine in Rats

  2005cites this paper
• Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression.

  2005cites this paper
• In vivo evidence for reduced cortical glutamate-glutamine cycling in rats treated with the antidepressant/antipanic drug phenelzine.

  2005cites this paper
• Natriuretic peptide interaction with [3H]isatin binding sites in rat brain.

  2005cites this paper
• MonoamineOxidaseInhibitionDramaticallyIncreasesthe MotivationtoSelf-AdministerNicotineinRats

  2005cites this paper
• Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine.

  2004cites this paper
• Social behavioural profile of cocaine in isolated and grouped male mice.

  2004cites this paper
• Effects of Hypericum perforatum and paroxetine in the mouse defense test battery.

  2003cites this paper
• The neurobiology and control of anxious states.

  2003cites this paper
• The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic.

  2003cites this paper
• Simultaneous determination of norepinephrine, serotonin, and 5-hydroxyindole-3-acetic acid in microdialysis samples from rat brain by microbore column liquid chromatography with fluorescence detection following derivatization with benzylamine.

  2003cites this paper
• Stimulation of P2Y1 Receptors Causes Anxiolytic-like Effects in the Rat Elevated Plus-maze: Implications for the Involvement of P2Y1 Receptor-Mediated Nitric Oxide Production

  2003cites this paper
• Conditioning and residual emotionality effects of predator stimuli: some reflections on stress and emotion.

  2003cites this paper
• The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.

  2003cites this paper
• Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine.

  2003cites this paper
• Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum.

  2002cites this paper
• Effects of the Antidepressant/Antipanic Drug Phenelzine on Alanine and Alanine Transaminase in Rat Brain

  2001cites this paper
• Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic.

  2001cites this paper
• Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.

  2000cites this paper
• Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT1A receptor antagonists

  1999cites this paper
• Cocaine potentiates defensive behaviors related to fear and anxiety.

  1999cites this paper
• Differences in anxiolytic-like profile of two novel nonbenzodiazepine BZ (omega) receptor agonists on defensive behaviors of mice.

  1999cites this paper
• Psychotropic and neurotropic activity

  1997cites this paper
• Digital Commons @ East Tennessee State University Digital Commons @ East Tennessee State University

  year unknowncites this paper